Answers are grounded in this paper and cite their sources.
and Lotte Bjerre Knudsen (Novo Nordisk) for their pioneering work on glucagon-like peptide 1 (GLP-1) receptor agonists and their applications to obesity.This recognition highlights the revolutionary work of these scientists that led to the discovery of one of the most exciting family of drugs in our lifetime.
No takes yet. Share an insight, caveat, or question.
Hossein Ardehali (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: